CL vs STRO
Colgate-Palmolive Company (CL) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. STRO currently screens at market cap $470.8M.
Not investment advice. Open the CL and STRO stock pages for the full models.
Not investment advice.